Scott Barraza

Scott Barraza

Company: PTC Therapeutics

Job title: Discovery Chemistry Group Leader


Next Generation Splicing Modulators 11:15 am

The approval of Risdiplam for the treatment of SMA validated the approach of selectively modulating splicing with small molecules PTC has developed a comprehensive discovery platform to identify novel splicing modulators for the treatment of diseases with unmet needs Novel splicing modulators are being optimized for recently identified disease-relevant splicing eventsRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.